Ampio Pharmaceuticals Pipeline

Ampio has a lead product candidate that is advancing through late-stage clinical trials in the United States. Ampio has initiated the second of two pivotal trials for Ampion, a biologic intra-articular injection being studied for the treatment of pain due osteoarthritis of the knee. Additional clinical trials are planned for this and other product candidates.